Darius P Zlotos

11PUBLICATIONS
22CO-AUTHORS
Proteins and peptidesCancer therapy (excl. chemotherapy and radiation therapy)Cheminformatics and quantitative structure-activity relationshipsBiologically active moleculesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 05, 2025
Synthesis and antiplasmodial activity of 6H,13H-pyrazino[1,2-a;4,5-a']diindole analogues substituted with basic side chains.

Darius P Zlotos, Siegrid Franke, Che J Ngwa

|Dec 09, 2024
Cancer Cells Show Higher Sensitivity to Melatonin-Tamoxifen Drug Conjugates than to Combination of Melatonin and Tamoxifen.

Mohamed Akmal Marzouk, Sara Greco, Florence Gbahou

|Oct 29, 2024
N-[4-(Benzyloxy)-3-methoxybenzyl)]adamantane-1-amine (DZH2), a dual CCR5 and CXCR4 inhibitor as a potential agent against triple negative breast cancer.

Monica M Rostom, Mariam A El-Zohairy, Mohamed A Marzouk

|Jun 20, 2023
Melatonin-vorinostat hybrid ligands show higher histone deacetylase and cancer cell growth inhibition than vorinostat.

Youssef Y Helmi, Niklas Papenkordt, Georg Rennar

|Apr 05, 2022
Strychnine and its mono- and dimeric analogues: a pharmaco-chemical perspective.

Darius P Zlotos, Yasmine M Mandour, Anders A Jensen

|Mar 14, 2022
Gefitinib-Tamoxifen Hybrid Ligands as Potent Agents against Triple-Negative Breast Cancer.

Carine M Abdelmalek, Zexi Hu, Thales Kronenberger

Pageof 2

Frequent Collaborators

4 joint publications

Christoph Sotriffer

4 joint publications

Ulrike Holzgrabe

3 joint publications

Hans-Georg Breitinger

3 joint publications

Paula A Witt-Enderby